Daejeon, South Korea

Tae Soo Kim

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Korea Institute of Oriental Medicine, Lg Energy Solution, Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tae Soo Kim. Retrieved from https://idiyas.com/inventor/tae-soo-kim-tc5bmfvj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tae Soo Kim in Osteoclast Inhibition

Introduction

Tae Soo Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicine, particularly in the area of bone health. His innovative work focuses on the development of natural compositions that can effectively inhibit osteoclasts, which are cells that break down bone tissue.

Latest Patents

Tae Soo Kim holds a patent for a composition aimed at inhibiting osteoclasts, which contains agastache rugosa extract as its active ingredient. This patent, titled "Composition for inhibiting osteoclasts containing agastache rugosa extract as active ingredient, and use thereof," highlights the potential of using plant-derived substances for medical applications. The extract or its components can be prepared from domestically cultivated plants, making it a cost-effective and time-efficient solution. This composition not only inhibits the differentiation and growth of osteoclast progenitor cells but also enhances bone density, making it a promising option for preventing and treating diseases related to bone loss.

Career Highlights

Tae Soo Kim is affiliated with the Korea Institute of Oriental Medicine, where he conducts research and develops innovative solutions for health-related issues. His work emphasizes the safety and efficacy of natural ingredients, which present fewer side effects compared to traditional chemical drugs. This focus on plant-derived substances positions him as a leader in the field of alternative medicine.

Collaborations

Tae Soo Kim collaborates with notable colleagues such as Hyun Il Ha and Youn Hwan Hwang. Their combined expertise contributes to the advancement of research in osteoclast inhibition and related health benefits.

Conclusion

Tae Soo Kim's innovative contributions to the field of osteoclast inhibition through natural compositions demonstrate the potential of plant-based solutions in medicine. His work not only addresses critical health issues but also paves the way for safer alternatives to chemical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…